Egle Therapeutics

Egle Therapeutics

Latest funding
€40,000,000
Venture capital (Series A) - 2021
Bpifrance Life Sciences Partners Fund+ +2
Team Size
1–10
Employees
Location
Headquarters
€40,000,000 Venture capital (Series A)
MedCity News

Already allied with Takeda, Egle raises €40M for its ‘starving’ immunotherapy